Published in Cell Reports Medicine, results of a VHIO-led study support the feasibility of using RAD51 testing to complement next-generation sequencing (NGS) for precise patient stratification and ...

co-leader of VHIO's Prostate Cancer Group, and co-corresponding author of this study. "However, several challenges of NGS testing still impede the widespread implementation of precision medicine ...

胰腺癌（ PC）是一种侵袭性肿瘤，在过去十年中，5年总生存率（ OS）基本保持不变，仅为12%。预计到2040年，PC将成为美国癌症相关死亡的第二大原因。尽管诊断时的中位年龄为71岁，但早发性胰腺癌（ EOPC）（ ...

在转移性疾病中，接受靶向治疗的EOPC患者生存率明显高于未接受靶向治疗者，显示出基因变异可能是治疗效果的关键。因此，医生应高度重视对所有胰腺癌患者，尤其是年轻患者，进行基因检测，以实现个性化治疗和更佳的保健结局。

Barcelona-based scientific leader brings insights and experience in translational oncology research and clinical development CAM ...

Co-Occurrence of Cytogenetic Abnormalities and High-Risk Disease in Newly Diagnosed and Relapsed/Refractory Multiple Myeloma A total of 121 patients (previous ICI-treated cohort, n = 31, and each of ...

Copyright: © 2025 The Author(s). Published by Elsevier Ltd.